Here, we found that TP53 pathogenic mutations were associated with the protein expression of ER and PR, as well as subtype (Table 1), suggesting that TP53 pathogenic mutations have a significant role in the molecular characterization of breast cancer. The gene discussed is TP53; the disease is breast carcinoma.